The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2 dose-escalation and dose-expansion study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma.
 
Viswatej Avutu
No Relationships to Disclose
 
Emily K Slotkin
Research Funding - Lilly (Inst); Lilly (Inst)
 
J Andrew Andrew Livingston
Consulting or Advisory Role - Isotopen Technologien
Research Funding - Repare Therapeutics (Inst)
Other Relationship - Guidepoint Global
 
Sant P. Chawla
Stock and Other Ownership Interests - AADi; Cellestia Biotech; Immix BioPharma
Honoraria - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Karyopharm Therapeutics; NKMax; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma; Tyme
Consulting or Advisory Role - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Karyopharm Therapeutics; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Speakers' Bureau - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Research Funding - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Janssen; Karyopharm Therapeutics; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
 
Joseph Gerald Pressey
Honoraria - CSRA
 
Preeya Nandkumar
Employment - Zentalis
Stock and Other Ownership Interests - Zentalis
 
Cheng Zheng
Employment - Zentalis
 
Soamnauth Misir
Employment - Urogen pharma; Zentalis
Stock and Other Ownership Interests - Johnson & Johnson/Janssen; Urogen pharma; Zentalis
 
Philippe Pultar
Employment - Novartis; Zeno Pharmaceuticals
Stock and Other Ownership Interests - Zeno Pharmaceuticals
 
Dimitris Voliotis
Employment - Zentalis
Stock and Other Ownership Interests - Zentalis
 
Katherine Anne Thornton
Consulting or Advisory Role - Epizyme; GlaxoSmithKline; More Health
 
Noah Federman
Stock and Other Ownership Interests - Reata Pharmaceuticals
Consulting or Advisory Role - Bayer; Loxo; Zelda Therapeutics
Speakers' Bureau - Bayer
Research Funding - Mirati Therapeutics